Six-Month Study of a Dietary Supplement to Improve Hair Growth in Men with Androgenetic Alopecia Aged 18 to 45

What this Trial Is About

This research aims to evaluate the effectiveness and safety of a dietary supplement called CL-P24113a for managing androgenetic alopecia AGA in men aged 18 to 45 years with mild to moderate hair loss. The study involves 45 male volunteers with low hair density classified as Hamilton-Norwood stages II, III, and IV. The supplement contains a blend of botanical ingredients such as Pumpkin Seed Oil, Saw Palmetto Oil, L-Cystine, Prunus africana Bark Extract, Horsetail Extract, and Olive Leaf Extract, all known for their safe use in hair and nail health. Participants will be randomly assigned to two groups 30 will receive the active dietary supplement and 15 will receive a placebo capsule identical in appearance. Each participant will take one capsule daily for six months, preferably in the morning with water. Before starting the treatment, all subjects must complete a 30-day washout period using a neutral shampoo and agree not to use other hair treatments during the study. The study is single-blind and placebo-controlled. Volunteers will have their hair health assessed instrumentally using the TrichoScan HD Professional 4.0 system at 3 and 6 months to measure various hair growth parameters, including hair count, density, thickness, and hair cycle phases. Subjective evaluations through questionnaires will be collected at 1.5, 3, 4.5, and 6 months to capture participants perceptions of hair growth and loss. Safety monitoring and adherence to study requirements will be ensured throughout the treatment period, which lasts six months.

Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers